Anzeige
Mehr »
Dienstag, 21.10.2025 - Börsentäglich über 12.000 News
Uran-Aktien gehen durch die Decke - diese Aktie könnte der nächste Highflyer sein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q | ISIN: CA74141E1043 | Ticker-Symbol: 18H
Frankfurt
21.10.25 | 08:02
0,016 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0160,02813:22

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoPreveCeutical Medical Inc.: PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.161NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - PreveCeutical Medical Inc. (CSE:...
► Artikel lesen
13.10.PreveCeutical Medical boosts private placement to $1.2M, following shareholder meeting approvals4
11.10.Preveceutical Medical Inc: Preveceutical hikes placement, releases AGSM results4
10.10.PreveCeutical Medical Inc.: PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement363Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all...
► Artikel lesen
20.09.Preveceutical Medical Inc: Preveceutical mails documents for Oct. 10 AGM4
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
20.09.PreveCeutical Medical Inc.: PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics847Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its...
► Artikel lesen
06.09.Preveceutical Medical Inc: Preveceutical closes $646,500 tranche one of placement4
05.09.PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement791Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that...
► Artikel lesen
04.09.PreveCeutical Medical Inc.: PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics414Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that it has entered...
► Artikel lesen
29.08.Preveceutical Medical Inc: Preveceutical reschedules AGM to Oct. 102
29.08.PreveCeutical Medical Inc.: PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation546Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that, further to its News...
► Artikel lesen
20.08.Preveceutical Medical Inc: Preveceutical's BioGene appoints chief tech officer1
20.08.PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer378Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
19.08.Preveceutical Medical Inc: Preveceutical's BioGene appoints research director1
19.08.PreveCeutical Medical Inc.: BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research223Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
05.08.Preveceutical Medical Inc: Preveceutical further reschedules AGSM to Sept. 293
09.07.Preveceutical Medical Inc: Preveceutical Medical reschedules AGSM to Sept. 55
09.07.PreveCeutical Medical Inc.: PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting257Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its News...
► Artikel lesen
01.07.Preveceutical Medical Inc: Preveceutical appoints Tavares chief technology officer2
30.06.PreveCeutical Medical Inc.: PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer404Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...
► Artikel lesen
Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1